Signaling by tumor necrosis factor receptors: pathways, paradigms and targets for therapeutic modulation.
Kaufman
D R
DR
Howard Hughes Medical Institute, Rockefeller University, New York, NY 10021, USA.
Choi
Y
Y
D000818:Animals; D015703:Antigens, CD / Q000502:physiology; D017209:Apoptosis; D006706:Homeostasis; D006801:Humans; D011506:Proteins / Q000502:physiology; D018124:Receptors, Tumor Necrosis Factor / Q000502:physiology*; D047888:Receptors, Tumor Necrosis Factor, Type I; D047889:Receptors, Tumor Necrosis Factor, Type II; D015398:Signal Transduction; D047990:TNF Receptor-Associated Factor 1; D047992:TNF Receptor-Associated Factor 2
D015703:Antigens, CD; D011506:Proteins; D018124:Receptors, Tumor Necrosis Factor; D047888:Receptors, Tumor Necrosis Factor, Type I; D047889:Receptors, Tumor Necrosis Factor, Type II; D047990:TNF Receptor-Associated Factor 1; D047992:TNF Receptor-Associated Factor 2